In summary, this review underscores the critical role of nitrogen heterocycles in pharmaceutical design, particularly in the development of angiotensin-converting enzyme inhibitors crucial for managing hypertension and cardiovascular conditions. This evidence concerns the gene ACE and Hypertension.